Barriers and facilitators of and strategies for successful community engagement in infectious disease clinical trials in low- and middle-income countries
| dc.contributor.author | Späth, chmidt, B.-M. C | |
| dc.date.accessioned | 2022-12-05T11:01:45Z | |
| dc.date.available | 2022-12-05T11:01:45Z | |
| dc.date.issued | 2022 | |
| dc.description.abstract | Objectives: This is a protocol for a Cochrane Review (qualitative). The objectives are as follows:. 1. To identify and synthesise barriers and facilitators of successful community engagement in infectious disease clinical trials (e.g. HIV, tuberculosis, and malaria) in low- and middle-income countries; and. 2. To identify and synthesise strategies for engaging community stakeholders in infectious disease clinical trials in low- and middle-income countries. Copyright © 2022 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. | en_US |
| dc.identifier.citation | John Wiley and Sons Ltd | en_US |
| dc.identifier.issn | 14651858 | |
| dc.identifier.uri | http://hdl.handle.net/10566/8251 | |
| dc.publisher | John Wiley and Sons Ltd | en_US |
| dc.subject | Export | en_US |
| dc.title | Barriers and facilitators of and strategies for successful community engagement in infectious disease clinical trials in low- and middle-income countries | en_US |
| dc.type | Article | en_US |